The present invention is directed to method of preventing or treating neural disease such as Alzheimer’s disease or inhibiting accumulation of β-amy-loid plaques in a subject by administering an effective dosage to the subject an agent (berberine) which inhibits the accumulation of β-amy-loid plaque.....
[更多]
The present invention relates to methods and an apparatus for developing, analyzing, investigating, supporting and advising healthcare and well-being related decisions.
[更多]
Use of dihydromyricetin (DMY) as an NF-κB inhibitor or an IKK-β inhibitor for the treatment of arthritis, cancer, autoimmune conditions and other disease is provided. A pharmaceutical composition comprising DMY is also provided.
[更多]
|<首頁 <-上一頁 下一頁-> 末頁>| |